عنوان مقاله [English]
The hly gene is one of the most important virulence factors of Listeria monocytogenes encoding listeriolysin O (LLO). LLO is a potent immunogenic protein eliciting both cellular and humoral immunity and has manyother functions besides hemolytic activity. This protein mediates the bacterial escape to the cytoplasm by disruption of phagosomal membrane leading to intracellular survival and proliferation of L. monocytogenes. On the other hand, Lactococcus lactis is a lactic acid bacterium which has many applications in expression of recombinant proteins. Our aim in this study was expression of recombinant LLO in L. lactis strain. Initially, the pTG19-T plasmid which is a T/A cloning vectorwas employed and then pNZ8110 was used as a Lactococcal secretional expression plasmid to clone L. monocytogenese hly gene by restriction enzymes cutting and ligation method. After cloning and propagation in E. coli MC1061 intermediate host, it was electro-transformed into L. lactis. Expression of LLO was confirmed by SDS-PAGE and western blot.
1-Bahey-El-Din, M., P. G. Casey , B.T. Griffin and C.G.M. Gahan. 2008. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model. Vaccine 26 (41): 5304-14.
2-Bahey-El Din, M., C.G.M. Gahan and B.T. Griffin. 2010a. Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Current Gene Therapy 10, 34-45.
3-Bahey El Din M., P. G. Casey, B.T. Griffin and C.G.M. Gahan. 2010b. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors. Journal of Medical Microbiology 20, 59 (Pt 8): 904-12.
4-Bermudez-Humaran, L.G. 2009. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins, Human Vaccines, 5:4, 264-267.
5-Cornell, K.A. et al.,1999. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. Journal of Immunology 163 : 322-329.
6-del Rio, B., J. F. M .L.Seegers and M.Gomes-Solecki. 2010. Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen. PLoS ONE 5(6): e11199.
7-Dramsi, S. and P. Cossart. 2002. Listeriolysin O a genuine cytolysin optimized for an intracellular parasite. Journal of Cell Biology 18, 156(6): 943–946.
8-Giammarini, C. and F. Andreoni. 2004 . Purification and characterization of a recombinant listeriolysin O expressed in Eschrichia coli and possible diagnostic applications. Journal of Biotechnology 109: 13-20.
9-Henrich, B., J.R. Klein, B. Weber, C. Delorm, P. Renault and U. Wegmann. 2002. Food grade delivery system for controlled gene expression in Lactococcuslactis. Applied & Environmental Microbiology, 68 (11) :5429-5436.
10-Huang, J.M., R.M. LaRagione, W.A. Cooley, S.Todry and S.M., Cutting. 2008 . Cytoplasmic delivery of antigens by Bacillus subtilis enhances Th1 responses. Vaccine 26 . 6043-6052.
11-Johnston, C., A.O. Coffey, J.M. Mahonyand R.D. Sleator. 2009. Development of a novel oral vaccine against Mycobacterium avium paratuberculosis and Johnẻ̉s disease. Bioengineered Bugs 1:2, 1-8.
12-Kayal, S. and A. Charbit. 2006. Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions. FEMS Microbiology Reviews 30, 4: 514-529.
13-Kunji, E.R., D.J. Slotboom and B. Poolman. 2003. Lactococcus lactis as host for overproduction of functional membrane proteins. Biochimistry Biophysic Acta 1610, 97-108.
14-Lety, M.A., C. Frehel, C. Raynaud, M. Dupuis and A. Charbit. 2006. Exploring the role of the CTL epitope region of listeriolysin O in the pathogenesis of Listeria monocytogenes. Microbiology152: 1287-96.
15-Leimeister-Wachter, M. and T. Chakraborty 1989. Detection of listeriolysin, thethiol dependent hemolysin in Listeria monocytogenes , Listeria ivanovii, and Listeria seeligeri. Infection and Immunity 57: 2350-2357.
16-Meyer-Morse, N. et al ., 2010. Listeriolysin O is necessary and sufficient to induce autophagy during Listeria monocytogenes infection. Journal PLoS ONE 5(1).
17-Mierau, I., and M. Kleerebezem. 2005. 10 years of nisin controlled gene expression system (NICE) in Lactococcus lactis. Applied Microbiology and Biotechnology.
18-NIZO food research BV. MoBiTec Molecular Biotechnology. 2010. NICE Expression System for Lactococcus lactis. Available online at: www.yrgene.com/documents/vector/nice.pdf.
19-Sambrook, J., and D.W. Russel. 2001. Molecular cloning.Third edition. New York , USA Cold Spring Harbor Laboratory Press.
20- Sirard, J.C., C. Fayolle, D.C. Chastollier, M. Mock, C. Leclerc and P. Borche. 1997 .Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus indicus CD8+ mediated protection against Listeria monocytogenes. Journal of Immunology 159(9). 4435-43.
21- Stachowiak, R., M. Lyzniak, M. Grabowska, K. Roeske, T. Jagielski, J. Bielecki, et al. 2014. Cytotoxicity of purified listeroplysin O on mouse and human leukocytes and leukemia cells. BMC Biotechnology .14 (77).
22- Vázquez-Boland,J.A., M. Kuhn, P. Berche, T. Chakraborty, G. Gustavo Domínguez-Bernal, et al.,2001. Listeria pathogenesis and molecular virulence determinants. Clinical Microbiology Review 14(3): 584–640.
23- Xu, J.J et al., 2006. Characterization of a recombinant Listeria monocytogenes strain containing the fusion protein gene of newcastle disease virus. Acta Microbiologica Sinica 43 (3) :445-450.
24- Yin, Y.L., X.A. Jiao, Z.M. Pan, X.M. Zhang and Z.Q. Gu. 2004. Prokaryotic expression and bioactivity of the Listeria monocytogenes listeriolysin O. Acta Microbiologica Sinica 44(6) : 752-755.